Early time-restricted eating and daytime bright light therapy may improve glycemic control in adults with type 2 diabetes
This protocol describes a 4-arm randomized controlled trial testing the independent and combined effects of early time-restricted eating (eTRE) and daytime bright light therapy (BLT) on glycemic control and other health outcomes in adults with type 2 diabetes. The trial will randomize 344 participants to one of four groups: control, eTRE, BLT, or eTRE+BLT, with an intensive 16-week intervention and follow-up at 1 year. The primary outcome is glycemic control measured by HbA1c and 24-hour glucose.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Early time-restricted eating and daytime bright light therapy may improve glycemic control in adults with type 2 diabetes The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 42/100 (low).
The Claim
Early time-restricted eating and daytime bright light therapy may improve glycemic control in adults with type 2 diabetes
This conclusion is most relevant to: Adults with insulin-independent type 2 diabetes.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Protocol for the CLOCKS study: A 4-arm randomized controlled trial testing the independent and combined effects of 2 chronotherapies-early time-restricted eating and daytime bright light therapy-in adults with type 2 diabetes. (Nutrition research (New York, N.Y.), 2026) —
How It Works
The proposed biological pathway:
- ▸Eating earlier in the day aligns food intake with circadian rhythms, improving glucose metabolism
- ▸Daytime bright light exposure strengthens circadian rhythms, enhancing melatonin and cortisol rhythms
- ▸Optimized circadian rhythms improve insulin sensitivity and glucose uptake
- ▸Result: Improved glycemic control and cardiometabolic health
Who Might Benefit
Evidence fit by population:
- ▸Adults with insulin-independent type 2 diabetes
Recommended Dose
eTRE: 8-hour eating window ending by 17:00; BLT: 90 minutes of bright light before 15:00 daily
Limitations & Caveats
Important context when interpreting this evidence:
- ▸This is a protocol paper, so results are not yet available; efficacy is not established
- ▸The intervention requires significant participant adherence (e.g., strict eating window, daily light therapy) which may affect feasibility and generalizability
- ▸The study population is limited to insulin-independent T2D, so findings may not apply to insulin-dependent patients
Frequently Asked Questions
What is early time-restricted eating (eTRE)?▼
eTRE is a form of intermittent fasting where all food is consumed within an 8-hour window that ends by 17:00 (5 PM).
What is daytime bright light therapy?▼
Daytime bright light therapy involves exposure to bright light for 90 minutes before 15:00 (3 PM) to strengthen circadian rhythms, combined with avoiding blue light at night.
What is the primary outcome of the CLOCKS study?▼
The primary outcome is glycemic control, measured by HbA1c and 24-hour glucose levels.
How long is the intervention period?▼
The intensive phase lasts 16 weeks, with a follow-up assessment at the 1-year mark.
References
- 1.Steger FL, Salvy SJ, Vaughan TB, Lowry C, Richman JS, Gamble KL, Garvey WT, Scheer FAJL, Peterson CM. “Protocol for the CLOCKS study: A 4-arm randomized controlled trial testing the independent and combined effects of 2 chronotherapies-early time-restricted eating and daytime bright light therapy-in adults with type 2 diabetes..” Nutrition research (New York, N.Y.), 2026. PMID: 42594524 DOI: 10.1016/j.nutres.2026.07.006